Molecular Dynamics (MD) simulation

Molecular Dynamics (MD) simulation is not just about generating trajectories — it is about decoding biomolecular behavior at the atomic level. 🧬💻

Different MD analyses provide unique insights into protein stability, flexibility, binding affinity, and conformational dynamics during simulations.

Some important MD analyses commonly used in computational drug discovery and structural biology include:

🔹 RMSD (Root Mean Square Deviation)
Evaluates overall structural stability throughout the simulation.

🔹 RMSF (Root Mean Square Fluctuation)
Identifies flexible and rigid regions of proteins.

🔹 Radius of Gyration (Rg)
Measures structural compactness and folding behavior.

🔹 SASA (Solvent Accessible Surface Area)
Analyzes solvent exposure and conformational changes.

🔹 Hydrogen Bond Analysis
Tracks stability and persistence of intermolecular interactions.

🔹 PCA (Principal Component Analysis)
Captures dominant collective motions and large-scale conformational changes.

🔹 Free Energy Landscape (FEL)
Reveals energetically favorable conformational states.

🔹 MM/PBSA or MM/GBSA
Estimates binding free energy and interaction energetics.

🔹 Secondary Structure Analysis (DSSP)
Monitors changes in α-helices, β-sheets, and other structural elements over time.

🔹 Dynamic Cross-Correlation Matrix (DCCM)
Studies correlated and anti-correlated residue motions.

🔹 Contact Map Analysis
Examines residue–residue interaction patterns during simulation.

🔹 Cluster Analysis
Groups similar conformations to identify dominant structural states.

🔹 Distance & Angle Analysis
Tracks important geometric changes between residues or ligands.

🔹 Essential Dynamics
Explores biologically significant motions within the trajectory.

🔹 Per-Residue Energy Decomposition
Identifies key residues contributing to ligand binding and stability.

Together, these analyses transform raw MD trajectories into meaningful biological and pharmacological insights for drug discovery and biomolecular dynamics

Comments

Curated Compendium of Drug Discovery

Drug discovery is a multidisciplinary process that integrates biology, chemistry, pharmacology , and cutting-edge technologies to identify and develop new therapeutic agents. From target identification to lead optimization and clinical evaluation, each stage requires precision, innovation, and collaboration. A curated list of drug discovery resources provides researchers, students, and professionals with a structured pathway to explore advancements, tools, and strategies that shape modern therapeutics. This compilation serves as a gateway to understanding the evolution of drug discovery, recent breakthroughs, and future directions, fostering knowledge-sharing and accelerating translational research. Databases and Chemical Libraries General Compound Libraries DrugBank - Comprehensive data on approved and investigational drugs. ZINC - Free compounds for screening. ChemSpider - Chemical structures and data. DrugSpaceX - Chemical and biological spaces. Mcule ...

Understanding NMR Spectroscopy and Chemical Shift Ranges for Functional Groups

Nuclear Magnetic Resonance ( NMR ) spectroscopy is one of the most powerful analytical tools in pharmaceutical chemistry. It helps chemists determine the structure, purity, and chemical environment of molecules by analyzing the behavior of nuclei (commonly ¹H or ¹³C ) when exposed to a strong magnetic field. In proton NMR ( ¹H-NMR ), the chemical shift (δ, in ppm) provides information about the type of hydrogen atoms present in a compound and their surrounding electronic environment. Depending on nearby atoms and functional groups, signals appear in specific regions of the spectrum — often referred to as upfield (shielded, lower δ values) or downfield (deshielded, higher δ values). The image above summarizes the characteristic δ ranges for different functional groups in ¹H-NMR. Let us break it down systematically: 1. Downfield Region (δ 12 – 6 ppm) Hydrogens in this region are strongly deshielded due to electronegative atoms or π-bond systems. Carboxylic Acids (–COOH) : δ 1...

Pushing the boundaries of computational drug discovery at Isomorphic Labs

The Isomorphic Labs Drug Design Engine (IsoDDE) has unlocked a new frontier in in-silico drug design, representing a significant evolution beyond AlphaFold 3. What IsoDDE delivers: 🔹 Massive accuracy leap on unconstrained structure prediction The engine more than doubles AlphaFold 3's accuracy on extremely challenging protein-ligand prediction tasks — including systems far outside the training distribution. 🔹 Best-in-class binding affinity prediction IsoDDE predicts how strongly small molecules bind to targets with accuracy that exceeds gold-standard physics-based methods, at a fraction of the computational cost and time. 🔹 Blind identification of novel binding pockets Even without existing structural data, the engine reveals previously unseen binding sites — just from an amino acid sequence — enabling drug designers to explore entirely new chemical action spaces. 🔹 Expanded support for complex biologics Beyond small molecules, the engine boosts prediction fidelity for...

NEOPHARMA NUTSHELL COMMUNITY

Search This Blog